At the cytokine level, chronic activation of the interferon-1 (IFN-1) pathway associated with PTEN loss has been demonstrated in prostate cancer studies which have immunosuppressive effects in contrast to the usual IFN-1 associated immunostimulatory and anti-tumor effects [24]. This evidence concerns the gene PTEN and neoplasm.